neracorvir

Action and Spectrum

Actions and Spectrum: 

Neracovir is a antiviral agent that targets the stages of life cycle. This includes fusion inhibitors, NRTIs, NNRTIs, CCR5 antagonists, integrase inhibitors, protease inhibitors that disrupts DNA and RNA polymerase and preventing the entry of virus. 

Drug Interaction

Adverse Reaction

Frequency not defined 

Not reported 

Black Box Warning

Black box warning: 

None 

Contraindication / Caution

Contraindications/caution: 

There is no specific information 

Pregnancy / Lactation

Pregnancy/Lactation 

Pregnancy consideration: Insufficient data available 

Lactation: Excretion of the drug in human breast milk is unknown 

Pregnancy category: 

Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester. 

Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women. 

Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women. 

Category D: adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits. 

Category X: Drugs listed in this category outweigh the risks over benefits. Hence, these categories of drugs need to be avoided by pregnant women. 

Category N: There is no data available for the drug under this category 

Pharmacology

Pharmacology: 

Limited data available 

Pharmacokinetics: 

There is no specific information 

Adminstartion

Administration: 

Limited data is available 

Patient Information Leaflet

Patient information leaflet 

Generic Name: neracorvir 

Why do we use neracorvir? 

It is an effective antiviral agent as it exhibits the anti-Hepatitis B activity.